Beijing Biostar Pharmaceuticals Co., Ltd. (HKG:2563)

HKG:2563 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	457.29	189.71	38.09	60.11	268.42	224.45
Short-Term Investments	-	268.74	302.32	224.17	-	-
Trading Asset Securities	65.8	105.99	235.61	444.99	536.96	654.07
Cash & Short-Term Investments	523.08	564.44	576.02	729.26	805.37	878.52
Cash Growth	-	-2.01%	-21.01%	-9.45%	-8.33%	290.61%
Accounts Receivable	12.46	23.15	11.16	34.62	25.12	-
Other Receivables	36.72	4.99	4.79	4.33	0.57	0.05
Receivables	49.18	28.14	15.95	38.95	25.81	0.36
Inventory	40.59	31.42	27.27	31.11	22.67	5.75
Restricted Cash	11.28	8.18	-	-	-	-
Other Current Assets	19.86	67.08	14.3	5.35	12.45	17.55
Total Current Assets	643.99	699.26	633.53	804.67	866.3	902.18
Property, Plant & Equipment	162.74	177.28	136.19	117.76	79.47	78.35
Other Intangible Assets	12.7	0.75	1.63	2.83	16.31	14.05
Other Long-Term Assets	35.96	35.95	1	1.07	1.99	1
Total Assets	855.38	913.24	772.34	926.34	964.06	995.58
Accounts Payable	52.95	48.33	24.44	20.1	4.28	2.48
Accrued Expenses	2.95	8.38	10.75	11.89	10	5.87
Current Portion of Leases	-	0.67	0.73	1.09	0.67	-
Current Income Taxes Payable	-	-	-	-	0	-
Current Unearned Revenue	0.27	4.72	-	-	1	1
Other Current Liabilities	9.07	17.07	7.83	18.64	2.21	2.35
Total Current Liabilities	65.88	79.16	43.74	51.73	18.16	11.7
Long-Term Leases	0.26	0.52	0.17	0.81	0.48	-
Long-Term Unearned Revenue	0.23	42.82	0.82	1.53	1.56	2.86
Other Long-Term Liabilities	42.45	-	4.45	4.35	-	-
Total Liabilities	108.81	122.5	49.18	58.41	20.2	14.56
Common Stock	364.59	364.59	350	350	350	34.99
Additional Paid-In Capital	1,308	-	-	-	972.05	1,200
Retained Earnings	-926.16	-	-	-	-378.19	-253.63
Comprehensive Income & Other	-0.25	426.16	373.16	517.93	-	-
Shareholders' Equity	746.57	790.75	723.16	867.93	943.87	981.02
Total Liabilities & Equity	855.38	913.24	772.34	926.34	964.06	995.58
Total Debt	0.9	1.18	0.9	1.9	1.14	-
Net Cash (Debt)	522.19	563.26	575.12	727.36	804.23	878.52
Net Cash Growth	-	-2.06%	-20.93%	-9.56%	-8.46%	290.61%
Net Cash Per Share	1.45	1.60	1.64	2.08	2.30	-
Filing Date Shares Outstanding	364.59	364.59	350	350	350	-
Total Common Shares Outstanding	364.59	364.59	350	350	350	-
Working Capital	578.11	620.1	589.79	752.95	848.14	890.48
Book Value Per Share	2.05	2.17	2.07	2.48	2.70	-
Tangible Book Value	733.86	789.99	721.53	865.09	927.56	966.97
Tangible Book Value Per Share	2.01	2.17	2.06	2.47	2.65	-
Buildings	-	75.42	72.76	72.69	67.93	59.9
Machinery	-	42.36	42.86	41.47	38.55	36.57
Construction In Progress	-	97.66	53.37	26.99	2.05	4.91

Source: S&P Global Market Intelligence. Standard template. Financial Sources.